Bright Minds Biosciences's total assets for Q2 2025 were C$56.47M, a decrease of -3.30% from the previous quarter. DRUG total liabilities were C$726.81K for the fiscal quarter, a 27.16% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.